Pipercuronium
Overview
Pipercuronium is a competitive blocking agent. It produces its action by blocking ganglions at motor end plate.It has been used for endotracheal intubation and to provide muscle relaxation in general anesthesia for surgical procedures and to aid mechanical ventilation.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Pipercuronium is contraindicated in conditions like Hypersensitivity.
Back to top
Back to top
Side Effects
Back to top
Dosage
Pipercuronium's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.07 to 0.085 mg/kg | 0.078 (0.0775) | As recommended. | | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Pipercuronium is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Pipercuronium is available. |
High Risk Groups
Back to top
Warning / Precautions
This drug should not be used in following conditions:
1. Myaesthenia gravis
2. Severe obesity
3. Malignant hyperthermia
Back to top
Storage Conditions
Back to top
Interference in Pathology
- Increased in serum creatinin
Back to top
Brands / Trade Names of
Pipercuronium
Back to top
Previous Drug Generic - Next Drug Generic